{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T09:01:12Z","timestamp":1770368472279,"version":"3.49.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Aortitis is a rare but critical manifestation of systemic inflammatory disease, most commonly associated with large-vessel vasculitides such as Takayasu arteritis and giant cell arteritis. When accompanied by multiorgan inflammation and fibrosis, it presents a broader diagnostic challenge that includes immune-mediated conditions such as immunoglobulin G4-related disease (IgG4-RD) and rare histiocytic neoplasms. While IgG4-RD is increasingly recognised due to improved diagnostic criteria and access to immunostaining, histiocytic neoplasms such as Erdheim\u2013Chester disease (ECD) remain underdiagnosed. ECD is a clonal histiocytic neoplasm driven by mutations in the mitogen-activated protein kinase pathway, with multisystem tissue infiltration and inflammation. Unlike IgG4-RD, ECD is amenable to targeted therapies. We present a diagnostically challenging case of a middle-aged woman referred with presumed IgG4-RD following five months of progressive retroperitoneal fibrosis, bilateral ureteric obstruction, weight loss, and fatigue. Further investigation revealed aortitis involving major branches, interstitial lung disease, and adrenal and pituitary involvement, but notably without skeletal disease. Omental biopsy confirmed ECD, with a pathogenic MAP2K1 mutation detected. This case highlights the diagnostic complexity of bone-sparing ECD, a phenotype present in fewer than five percent of cases. Its clinical mimicry of vasculitis and other inflammatory disorders can obscure the underlying neoplastic process, delaying diagnosis and access to effective treatment. In patients with systemic inflammation and inconclusive serology, early consideration of ECD is essential to guide appropriate investigations and timely therapy.<\/jats:p>","DOI":"10.1093\/mrcr\/rxag001","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:38:44Z","timestamp":1769171924000},"source":"Crossref","is-referenced-by-count":0,"title":["Erdheim\u2013Chester disease mimicking IgG4-related disease"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8378-5135","authenticated-orcid":false,"given":"Katherine E","family":"Moore","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Flinders Medical Centre , Adelaide, South Australia ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9317-5254","authenticated-orcid":false,"given":"Gabriella","family":"Venter","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Flinders Medical Centre , Adelaide, South Australia ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P","family":"Slavotinek","sequence":"additional","affiliation":[{"name":"College of Medicine and Public Health, Flinders University , Adelaide, South Australia ,","place":["Australia"]},{"name":"South Australian Medical Imaging, Flinders Medical Centre , Bedford Park, South Australia ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6668-9638","authenticated-orcid":false,"given":"Mihir D","family":"Wechalekar","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Flinders Medical Centre , Adelaide, South Australia ,","place":["Australia"]},{"name":"College of Medicine and Public Health, Flinders University , Adelaide, South Australia ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"2026020409470493700_ref1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13075-020-02197-w","article-title":"IgG4-related aortitis\/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease","volume":"22","author":"Peng","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2026020409470493700_ref2","first-page":"1311","article-title":"Erdheim-Chester disease","volume":"135","author":"Haroche","year":"2020","journal-title":"Blood, J Am Soc Hematol"},{"key":"2026020409470493700_ref3","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/cancers11101618","article-title":"A comprehensive review on MAPK: a promising therapeutic target in cancer","volume":"11","author":"Braicu","year":"2019","journal-title":"Cancers"},{"key":"2026020409470493700_ref4","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1002\/cncr.28864","article-title":"The MAPK pathway across different malignancies: a new perspective","volume":"120","author":"Burotto","year":"2014","journal-title":"Cancer"},{"key":"2026020409470493700_ref5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.1026","article-title":"Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma","volume":"44","author":"Nikolaev","year":"2012","journal-title":"Nat Genet"},{"key":"2026020409470493700_ref6","first-page":"1929","article-title":"Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era","volume":"135","author":"Goyal","year":"2020","journal-title":"Blood, J Am Soc Hematol"},{"key":"2026020409470493700_ref7","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1182\/blood.2024028032","article-title":"Long-term outcomes with single-agent BRAF inhibitor therapy in Erdheim-Chester disease","volume":"145","author":"Goyal","year":"2025","journal-title":"Blood"},{"key":"2026020409470493700_ref8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-019-1012-y","article-title":"Efficacy of MEK inhibition in patients with histiocytic neoplasms","volume":"567","author":"Diamond","year":"2019","journal-title":"Nature"},{"key":"2026020409470493700_ref9","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/s41375-025-02526-5","article-title":"Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants","volume":"39","author":"Acosta-Medina","year":"2025","journal-title":"Leukemia"},{"key":"2026020409470493700_ref10","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/1078-0432.CCR-14-2124","article-title":"MAP2K1 (MEK1) mutations define a distinct subset of lung adenocarcinoma associated with smoking","volume":"21","author":"Arcila","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2026020409470493700_ref11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/carcin\/bgs099","article-title":"Oncogenic MAP2K1 mutations in human epithelial tumors","volume":"33","author":"Choi","year":"2012","journal-title":"Carcinogenesis"},{"key":"2026020409470493700_ref12","doi-asserted-by":"crossref","first-page":"20411","DOI":"10.1073\/pnas.0905833106","article-title":"MEK1 mutations confer resistance to MEK and B-RAF inhibition","volume":"106","author":"Emery","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"2026020409470493700_ref13","doi-asserted-by":"crossref","DOI":"10.1182\/hem.V14.4.7476","article-title":"Histiocytoses: clonal disorders of hematopoiesis driven by MAP kinase signaling","volume":"14","author":"Abdel-Wahab","year":"2017","journal-title":"Hematol"},{"key":"2026020409470493700_ref14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","article-title":"Diverse and targetable kinase alterations drive histiocytic neoplasms","volume":"6","author":"Diamond","year":"2016","journal-title":"Cancer Discov"},{"key":"2026020409470493700_ref15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/1535-7163.MCT-22-0302","article-title":"High-throughput functional evaluation of MAP2K1 variants in cancer","volume":"22","author":"Mizuno","year":"2023","journal-title":"Mol Cancer Ther"},{"key":"2026020409470493700_ref16","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2214\/ajr.183.5.1831253","article-title":"Imaging of thoracoabdominal involvement in Erdheim-Chester disease","volume":"183","author":"Dion","year":"2004","journal-title":"Am J Roentgenol"},{"key":"2026020409470493700_ref17","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.3390\/cancers13164126","volume":"13","author":"Shekhar","year":"2021","journal-title":"Cancers."},{"key":"2026020409470493700_ref18","first-page":"15","article-title":"Neuroradiologic manifestations of Erdheim-Chester disease","volume":"8","author":"Parks","year":"2018","journal-title":"Neurology: Clinical Practice"},{"key":"2026020409470493700_ref19","doi-asserted-by":"crossref","DOI":"10.1210\/js.2019-OR32-1","article-title":"OR32-1 endocrine manifestations of erdheim-Chester disease: the Mayo Clinic experience","volume":"3","author":"Hurtado","year":"2019","journal-title":"J Endocr Soc"},{"key":"2026020409470493700_ref20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.berh.2012.07.001","article-title":"IgG4-related diseases","volume":"26","author":"Guma","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2026020409470493700_ref21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11102-016-0773-7","article-title":"Critical review of IgG4-related hypophysitis","volume":"20","author":"Shikuma","year":"2017","journal-title":"Pituitary"},{"key":"2026020409470493700_ref22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12022-018-9531-x","article-title":"IgG4-associated Adrenalitis\u2014a case report","volume":"29","author":"Saeger","year":"2018","journal-title":"Endocr Pathol"},{"key":"2026020409470493700_ref23","doi-asserted-by":"crossref","first-page":"e13452","DOI":"10.1097\/MD.0000000000013452","article-title":"Arterial involvement in Erdheim-Chester disease: a retrospective cohort study","volume":"97","author":"Villatoro-Villar","year":"2018","journal-title":"Medicine."},{"key":"2026020409470493700_ref24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-4-431-55687-9_14","volume-title":"IgG4-Related Kidney Disease","author":"Mizushima","year":"2016"},{"key":"2026020409470493700_ref25","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1161\/CIRCULATIONAHA.108.825075","article-title":"Cardiac involvement in Erdheim-Chester disease: magnetic resonance and computed tomographic scan imaging in a monocentric series of 37 patients","volume":"119","author":"Haroche","year":"2009","journal-title":"Circulation"},{"key":"2026020409470493700_ref26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13023-024-03266-y","article-title":"Coronary periarteritis and pericarditis are rare but distinct manifestations of heart involvement in IgG4-related disease: a retrospective cohort study","volume":"19","author":"Hua","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"2026020409470493700_ref27","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1093\/eurheartj\/ehad655.2767","article-title":"Investigating the cardiac manifestations of IgG4-related disease using cardiac magnetic resonance imaging","volume":"44","author":"Henry","year":"2023","journal-title":"Eur Heart J"},{"key":"2026020409470493700_ref28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/jcm7090243","volume":"7","author":"Haroutunian","year":"2018","journal-title":"J Clin Med"},{"key":"2026020409470493700_ref29","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1007\/s00330-018-5421-3","article-title":"Thoracic involvement in Erdheim-Chester disease: computed tomography imaging findings and their association with the BRAF V600E mutation","volume":"28","author":"Mirmomen","year":"2018","journal-title":"Eur Radiol"},{"key":"2026020409470493700_ref30","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00296-024-05611-7","article-title":"Pulmonary manifestations, treatments and outcomes of IgG4-related disease\u2013a systematic literature review","volume":"44","author":"Dragos","year":"2024","journal-title":"Rheumatol Int"},{"key":"2026020409470493700_ref31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12026-016-8863-1","article-title":"Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease","volume":"65","author":"De Virgilio","year":"2017","journal-title":"Immunol Res"},{"key":"2026020409470493700_ref32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","article-title":"IgG4-related disease: an update on pathophysiology and implications for clinical care","volume":"16","author":"Perugino","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2026020409470493700_ref33","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1002\/art.27672","article-title":"Pulmonary involvement in Erdheim-Chester disease: a single-center study of thirty-four patients and a review of the literature","volume":"62","author":"Arnaud","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2026020409470493700_ref34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-230X-11-77","article-title":"Unusual manifestation of Erdheim-Chester disease","volume":"11","author":"Pan","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"2026020409470493700_ref35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/modpathol.2017.160","article-title":"The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort","volume":"31","author":"Ozkaya","year":"2018","journal-title":"Mod Pathol"},{"key":"2026020409470493700_ref36","doi-asserted-by":"crossref","DOI":"10.5812\/iranjradiol.119390","article-title":"A case of Erdheim-Chester disease with omental caking initially mistaken for a malignancy","volume":"19","author":"Rasuli","year":"2022","journal-title":"Iran J Radiol"},{"key":"2026020409470493700_ref37","author":"Yalamanchili"},{"key":"2026020409470493700_ref38","doi-asserted-by":"crossref","first-page":"876294","DOI":"10.3389\/fcvm.2022.876294","article-title":"Genetics and clinical phenotype of Erdheim\u2013Chester disease: a case report of constrictive pericarditis and a systematic review of the literature","volume":"9","author":"Bartoli","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026020409470493700_ref39","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/blood-2005-06-2238","article-title":"Successful treatment of Erdheim-Chester disease, a non\u2013Langerhans-cell histiocytosis, with interferon-\u03b1","volume":"106","author":"Braiteh","year":"2005","journal-title":"Blood"},{"key":"2026020409470493700_ref40","first-page":"1023","article-title":"Cladribine for the management of Erdheim-Chester disease in adults","volume":"2016","author":"Patel","year":"2016","journal-title":"Ann Clin Case Rep"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxag001\/66575425\/rxag001.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/1\/rxag001\/66575425\/rxag001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/1\/rxag001\/66575425\/rxag001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T14:47:12Z","timestamp":1770216432000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxag001\/8440982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxag001","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rxag001"}}